MAPT and dementia: Therefore, detecting aberrations in the levels of both CSF Aβ1-42 and p-tau (i.e., A+T+) can define the pathologic state through the Alzheimer’s continuum, i.e., preclinical AD, prodromal AD, and AD with dementia.